These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 25155313)

  • 1. Venous thromboembolism risk factors in Chinese non-small cell lung cancer patients.
    Wang Z; Yan HH; Yang JJ; Wang BC; Chen HJ; Zhou Q; Xu CR; Jiang BY; Wu YL
    Support Care Cancer; 2015 Mar; 23(3):635-41. PubMed ID: 25155313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of venous thromboembolism among patients with primary lung cancer.
    Chew HK; Davies AM; Wun T; Harvey D; Zhou H; White RH
    J Thromb Haemost; 2008 Apr; 6(4):601-8. PubMed ID: 18208538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer.
    Lee YG; Kim I; Lee E; Bang SM; Kang CH; Kim YT; Kim HJ; Wu HG; Kim YW; Kim TM; Lee KW; Lee SH; Kim DW; Heo DS
    Thromb Haemost; 2014 Jun; 111(6):1112-20. PubMed ID: 24477503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced nodal stage predicts venous thromboembolism in patients with locally advanced non-small cell lung cancer.
    Li R; Hermann G; Baldini E; Chen A; Jackman D; Kozono D; Nguyen P; Nohria A; Powell G; Mak R
    Lung Cancer; 2016 Jun; 96():41-7. PubMed ID: 27133748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer.
    Khorana AA; Palaia J; Rosenblatt L; Pisupati R; Huang N; Nguyen C; Barron J; Gallagher K; Bond TC
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous thromboembolism and nonsmall cell lung cancer: a pooled analysis of National Cancer Institute of Canada Clinical Trials Group trials.
    Hicks LK; Cheung MC; Ding K; Hasan B; Seymour L; Le Maître A; Leighl NB; Shepherd FA
    Cancer; 2009 Dec; 115(23):5516-25. PubMed ID: 19711465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients.
    Connolly GC; Menapace L; Safadjou S; Francis CW; Khorana AA
    Clin Lung Cancer; 2013 Nov; 14(6):713-8. PubMed ID: 23891560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk prediction of venous thromboembolism in non-small cell lung cancer patients based on COMPASS-CAT risk assessment model].
    Wang YF; Ma F; Liu BL; Yang K; Li JL; Yu L
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):340-345. PubMed ID: 32375452
    [No Abstract]   [Full Text] [Related]  

  • 9. Postoperative venous thromboembolism after surgery for stage IA non-small-cell lung cancer: A single-center, prospective cohort study.
    Dong H; Liang X; Gao Y; Cai Y; Li X; Miao J; Wang W; Hu B; Li H
    Thorac Cancer; 2022 May; 13(9):1258-1266. PubMed ID: 35315227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Venous thromboembolism with EGFR monoclonal antibody necitumumab in stage IV non-small cell lung cancer: A retrospective cohort analysis.
    Young K; Paz-Ares L; Thatcher N; Spigel DR; Shahidi J; Soldatenkova V; Grau G; Kurek R; Shepherd FA
    Thromb Res; 2018 Jul; 167():50-56. PubMed ID: 29787943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Venous Thromboembolism in Patients With Stage III and IV Non-Small-Cell Lung Cancer: Nationwide Descriptive Cohort Study.
    Ording AG; Christensen TD; Skjøth F; Noble S; Højen AA; Mørkved AL; Larsen TB; Petersen RH; Meldgaard P; Jakobsen E; Søgaard M
    Clin Lung Cancer; 2024 Jul; 25(5):407-416.e1. PubMed ID: 38705834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Analysis of incidence and risk factors for postoperative venous thromboembolism in patients with stageⅠ a non-small-cell lung cancer].
    Dong HH; Cai YS; Liang XN; Miao JB; Chen QS; Gao YD; Li H
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(41):3417-3421. PubMed ID: 34758546
    [No Abstract]   [Full Text] [Related]  

  • 13. ALK-Rearranged Non-Small-Cell Lung Cancer Is Associated With a High Rate of Venous Thromboembolism.
    Zer A; Moskovitz M; Hwang DM; Hershko-Klement A; Fridel L; Korpanty GJ; Dudnik E; Peled N; Shochat T; Leighl NB; Liu G; Feld R; Burkes R; Wollner M; Tsao MS; Shepherd FA
    Clin Lung Cancer; 2017 Mar; 18(2):156-161. PubMed ID: 27913214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a nomogram to assess postoperative venous thromboembolism risk in patients with stage IA non-small cell lung cancer.
    Cai Y; Dong H; Li X; Liu Y; Hu B; Li H; Miao J; Chen Q
    Cancer Med; 2023 Jan; 12(2):1217-1227. PubMed ID: 35758614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of D-dimer in non-small cell lung cancer patients receiving radical surgery and its association with postoperative venous thromboembolism.
    Ke L; Cui S; Chen S; Hu B; Li H
    Thorac Cancer; 2020 Sep; 11(9):2483-2492. PubMed ID: 32657038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venous thromboembolism in non-small cell lung cancer patients who underwent surgery after induction therapy.
    Kaminuma Y; Tanahashi M; Suzuki E; Yoshii N; Niwa H
    Gen Thorac Cardiovasc Surg; 2020 Oct; 68(10):1156-1162. PubMed ID: 32274676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
    Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
    Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk and Timing of Venous Thromboembolism After Surgery for Lung Cancer: A Nationwide Cohort Study.
    Mørkved AL; Søgaard M; Skjøth F; Ording AG; Jensen M; Larsen TB; Jakobsen E; Højen AA; Noble S; Meldgaard P; Petersen RH; Christensen TD
    Ann Thorac Surg; 2024 Feb; 117(2):289-296. PubMed ID: 37890818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and prognosis value of venous thromboembolism in patients with advanced non-small cell lung cancer: a case-control study.
    Shen Q; Dong X; Tang X; Zhou J
    J Thorac Dis; 2017 Dec; 9(12):5068-5074. PubMed ID: 29312712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma levels of soluble P-Selectin and Factor VIII predict venous thromboembolism in non-small cell lung cancer patients: The Thrombo-Nsclc risk score.
    Castellón Rubio VE; Segura PP; Muñoz A; Farré AL; Ruiz LC; Lorente JA
    Thromb Res; 2020 Dec; 196():349-354. PubMed ID: 32977135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.